Activation of the Ras/mitogen-activated protein kinase pathway by kinase-defective epidermal growth factor receptors results in cell survival but not proliferation

Molecular and Cellular Biology

Volumn 18, Issue 12, 1998, Pages 7192-7204

  Walker, Francesca ^a,b   Kato, Akiko ^a,b   Gonez, L Jorge ^a,b   Hibbs, Margaret L ^a   Pouliot, Normand ^b   Levitzki, Alexander ^c   Burgess, Antony W ^a,b  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MUTANT PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE; RAS PROTEIN;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; DIMERIZATION; ENZYME ACTIVATION; ENZYME ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALIA; MURINAE;

EID: 0031782321     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.12.7192     Document Type: Article

References (82)

1. Agarwal, A., P. Salem, and K. C. Robbins. 1993. Involvement of p72syk, a protein-tyrosine kinase, in Fc gamma receptor signaling. J. Biol. Chem. 268: 15900-15905.
2. Alessi, D. R., Y. Saito, D. G. Campbell, P. Cohen, G. Sithanandam, U. Rapp, A. Ashworth, C. J. Marshall, and S. Cowley. 1994. Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1. EMBO J. 13:1610-1619.
3. Barone, M. V., and S. A. Courtneidge. 1995. Myc hut not Fos rescue of PDGF signalling block caused by kinase-inactive Src. Nature 378:509-512.
4. Bertics, P. J., W. S. Chen, L. Hubler, C. S. Lazar, M. G. Rosenfeld, and G. N. Gill. 1988. Alteration of epidermal growth factor receptor activity by mutation of its primary carboxyl-terminal site of tyrosine self-phosphorylation. J. Biol. Chem. 263:3610-3617.
5. Blenis, J. 1993. Signal transduction via the MAP kinases: proceed at your own RSK. Proc. Natl. Acad. Sci. USA 90:5889-5892.
6. Boulton, T. G., S. H. Nye, D. J. Robbins, N. Y. Ip, E. Radziejewska, S. D. Morgenhesser, R. A. DePinto, N. Panaytos, M. H. Cobb, and G. D. Yancopaulos. 1991. ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65:663-675.
7. Broome, M. A., and T. Hunter. 1996. Requirement for c-Src catalytic activity and the SH3 domain in platelet-derived growth factor BB and epidermal growth factor mitogenic signaling. J. Biol. Chem. 271:16798-16806.
8. Brunet, A., G. Pages, and J. Pouyssegur. 1994. Constitutively active mutants of MAP kinase kinase (MEK1) induce growth factor-relaxation and encogenicity when expressed in fibroblasts. Oncogene 9:3379-3387.
9. Burgess, A. W. 1996. Mammals I: regulation of Ras activation, p. 75-94. In H. Maruta and A. W. Burgess (ed.), Regulation of the RAS signaling network. R. G. Landes Co., Austin, Tex.
10. Burgess, A. W., C. J. Lloyd, and E. C. Nice. 1983. Murine epidermal growth factor: heterogeneity on high resolution ion-exchange chromatography. EMBO J. 2:2065-2069.
11. Carraway, K. L., III, and L. C. Cantley. 1994. A new acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling. Cell 78:5-8.
12. Carraway, K. L., and C. A. Carraway. 1995. Signaling, mitogenesis and the cytoskeleton: where the action is. Bioessays 17:171-175.
13. Chen, W. S., C. S. Lazar, M. Poenie, R. Y. Tsien, G. N. Gill, and M. G. Rosenfeld. 1987. Requirement for intrinsic protein tyrosine kinase in the immediate and late actions of the EGF receptor. Nature 828:820-823.
14. Coker, K. J., J. V. Staros, and C. A. Guyer. 1994. A kinase-negative epidermal growth factor receptor that retains the capacity to stimulate DNA synthesis. Proc. Natl. Acad. Sci. USA 91:6967-6971.
15. Daley, G. Q., and D. Baltimore. 1988. Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein. Proc. Natl. Acad. Sci. USA 85:9312-9316.
16. Damen, J. E., L. Liu, P. Rosten, R. K. Humphries, A. B. Jefferson, P. W. Majerus, and G. Krystal. 1996. The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase. Proc. Natl. Acad. Sci. USA 93: 1689-1693.
17. Daum, G., I. Eisenmann-Tappe, H.-W. Fries, J. Troppmair, and U. R. Rapp. 1994. The ins and outs of Raf kinases. Trends Biochem. Sci. 19:474-480.
18. Dudley, D. T., L. Pang, S. J. Decker, A. J. Bridges, and A. R. Saltiel. 1995. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA 92:7686-7689.
19. Duronio, V., M. J. Welham, S. Abraham, P. Dryden, and J. W. Schrader. 1992. p21ras activation via hemopoietin receptors and c-kit requires tyrosine kinase activity but not tyrosine phosphorylation of p21 ras GTPase-activating protein. Proc. Natl. Acad. Sci. USA 89:1587-1591.
20. Egan, S. E., B. W. Giddings, M. W. Brookes, L. Buday, A. M. Sizeland, and R. A. Weinberg. 1993. Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature 363:45-51.
21. Erpel, T., and S. A. Courtneidge. 1995. Src family protein tyrosine kinases and cellular signal transduction pathways. Curr. Opin. Cell Biol. 7:176-182.
22. Fowler, K. J., F. Walker, W. Alexander, M. L. Hibbs, E. C. Nice, R. M. Bohmer, G. B. Mann, C. Thumwood, R. Maglitto, J. A. Danks, R. Chetty, A. W. Burgess, and A. R. Dunn. 1995. A mutation in the epidermal growth factor receptor in waved-2 mice has a profound effect on receptor biochemistry that results in impaired lactation. Proc. Natl. Acad. Sci. USA 92:1465-1469.
23. Fridell, Y.-W., Y. Jin, L. A. Quilliam, A. Burchert, P. McCloskey, G. Spizz, B. Varnum, C. Der, and E. T. Liu. 1996. Differential activation of the Ras/extracellular-signal-regulated protein kinase pathway is responsible for the biological consequences induced by the Axl receptor tyrosine kinase. Mol. Cell. Biol. 16:135-145.
24. Furth, M. E., L. J. Davis, B. Fleurdelys, and E. M. Skolnik. 1982. Monoclonal antibodies to the p21 products of the transforming gene of Harvey murine sarcoma virus and of the cellular ras gene family. J. Virol. 43:294-304.
25. Gill, G. N., T. Kawamoto, C. Cochet, A. Le, J. D. Sato, H. Masui, A. McLeod, and J. Mendelsohn. 1984. Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase activity. J. Biol. Chem. 259:7755-7760.
26. Glenney, J. R., Jr., W. S. Chen, C. S. Lazar, G. M. Walton, L. M. Zokas, M. G. Rosenfeld, and G. N. Gill. 1988. Ligand-induced endocytosis of the EGF receptor is blocked by mutational inactivation and by microinjection of anti-phosphotyrosine antibodies. Cell 52:675-684.
27. Gotoh, N., A. Tojo, K. Muroya, Y. Hashimoto, S. Hattori, S. Nakamura, T. Takenawa, Y. Yazaki, and M. Shibuya. 1994. Epidermal growth factor-receptor mutant lacking the autophosphorylation sites induces phosphorylation of Shc protein and Shc-Grb2/ASH association and retains mitogenic activity. Proc. Natl. Acad. Sci. USA 91:167-171.
28. Gotoh, N., K. Muroya, S. Hattori, S. Nakamura, K. Chida, and M. Shibuya. 1995. The SH2 domain of Shc suppresses EGF-induced mitogenesis in a dominant negative manner. Oncogene 11:2525-2533.
29. Groenen, L. C., E. C. Nice, and A. W. Burgess. 1994. Structure-function relationships for the EGF/TGF-alpha family of mitogens. Growth Factors 11:235-257.
30. Hanke, J. H., J. P. Gardner, R. L. Dow, P. S. Changelian, W. H. Brissette, E. J. Weringer, B. A. Pollok, and P. A. Connelly. 1996. Discovery of a novel, potent and Src-family selective tyrosine kinase inhibitor. J. Biol. Chem. 271: 695-701.
31. Heldin, C.-H. 1995. Dimerization of cell surface receptors in signal transduction. Cell 80:213-223.
32. Huang, C., W. Y. Ma, and Z. Dong. 1996. Requirement for phosphatidylinositol 3-kinase in epidermal growth factor-induced AP-1 transactivation and transformation in JB6 P+ cells. Mol. Cell. Biol. 16:6427-6435.
33. Jaiswal, R. K., S. A. Moodie, A. Wolfman, and G. E. Landreth. 1994. The mitogen-activated protein kinase cascade is activated by B-Raf in response to nerve growth factor through interaction with p21ras. Mol. Cell. Biol. 14: 6944-6953.
34. Jelinek, T., A. D. Catling, C. W. Reuter, S. A. Moodie, A. Wolfman, and M. J. Weber. 1994. RAS and RAF-1 form a signalling complex with MEK-1 but not MEK-2. Mol. Cell. Biol. 14:8212-8218.
35. Karin, M., and T. Smeal. 1992. Control of transcription factors by signal transduction pathways: the beginning of the end. Trends Biochem. Sci. 17: 418-422.
36. Kinoshita, T., K. A. Yokota, and A. Miyajima. 1995. Suppression of apoptotic death in hematopoietic cells by signalling through the IL3/GM-CSF receptors. EMBO J. 14:266-275.
37. Kolch, W., A. Philipp, H. Mischak, E. M. Dutil, T. M. Mullen, J. R. Feramisco, J. L. Meinkoth, and D. W. Rose. 1996. Inhibition of Raf-1 signaling by a monoclonal antibody, which interferes with Raf-1 activation and with Mek substrate binding. Oncogene 13:1305-1314.
38. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
39. Lee, K. F., H. Simon, H. Chen, B. Bates, M. C. Hung, and C. Hauser. 1995. Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature 378:394-398.
40. Leevers, S. J., and C. J. Marshall. 1992. Activation of extracellular signal-regulated kinase, ERK2, by p21ras oncoprotein. EMBO J. 11:569-574.
41. Leone, G., J. DeGregori, R. Sears, L. Jakoi, and J. R. Nevins. 1997. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature 387:422-426.
42. Lioubin, M. N., G. M. Myles, K. Carlberg, D. Bowtell, and L. R. Rohrscheneider. 1994. Shc, Grb2, Sos1, and a 150-kilodalton tyrosine-phosphorylated protein form complexes with Fms in hematopoietic cells. Mol. Cell Biol. 14: 5682-5691.
43. Liu, L., J. E. Damen, M. R. Hughes, I. Babic, F. R. Jirik, and G. Krystal. 1997. Interleukin-3 induces the association of the inositol 5-phosphatase SHIP with SHP2. J. Biol. Chem. 272:8983-8988.
44. Lowenstein, E. J., R. J. Daly, A. G. Batzer, W. Li, B. Margolis, R. Lammers, A. Ullrich, E. Y. Skolnik, D. Bar-Sagi, and J. Schlessinger. 1992. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell 70:431-442.
45. Luetteke, N. C., H. K. Phillips, T. H. Qiu, N. G. Copeland, H. S. Earp, N. A. Jenkins, and D. C. Lee. 1994. The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase. Genes Dev. 8:399-413.
46. Matsuguchi, T., R. Salgia, M. Hallek, M. Eder, B. Druker, T. J. Ernst, and J. D. Griffin. 1994. Shc phosphorylation in myeloid cells is regulated by granulocyte macrophage colony-stimulating factor, interleukin-3, and steel factor and is constitutively increased by p210BCR/ABL. J. Biol. Chem. 269: 5016-5021.
47. McCormick, F. 1993. Signal transduction. How receptors turn Ras on. Nature 363:15-16.
48. Meydan, N., T. Grunberger, H. Dadi, M. Shashar, E. Arpaia, Z. Lapidot, J. S. Leeder, M. Freedman, A. Cohen, A. Gazit, A. Levitzki, and C. M. Roifman. 1996. Inhibition of acute lymphoblastic leukemia by a Jak-2 inhibitor. Nature 379:645-648.
49. Moodie, S. A., M. J. Paris, W. Kolch, and A. Wolfman. 1994. Association of MEK1 with p21ras.GMPPNP is dependent on B-Raf. Mol. Cell. Biol. 14: 7153-7162.
50. Moolenaar, W. H., A. J. Bierman, B. C. Tilly, I. Verlaan, L. H. Defize, A. M. Honegger, A. Ullrich, and J. Schlessinger. 1988. A point mutation at the ATP-binding site of the EGF-receptor abolishes signal transduction. EMBO J. 7:707-710.
51. Murillas, R., F. Larcher, C. J. Conti, M. Santos, A. Ullrich, and J. L. Jorcano. 1995. Expression of a dominant negative mutant of epidermal growth factor receptor in the epidermis of transgenic mice elicits striking alterations in hair follicle development and skin structure. EMBO J. 14: 5216-5223.
52. Nakielny, S., P. Cohen, J. Wu, and T. W. Sturgill. 1992. MAP kinase activator from insulin-stimulated skeletal muscle is a protein threonine/tyrosine kinase. EMBO J. 11:2123-2129.
53. Ono, M., H. Okada, S. Bolland, S. Yanagi, T. Kurosaki, and J. V. Ravetch. 1997. Deletion of SHIP or SHP-1 reveals two distinct pathways for inhibitory signaling. Cell 90:293-301.
54. Palacios, R., and M. Steinmetz. 1985. IL-3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo. Cell 41:727-734.
55. Pawson, T., and J. D. Scott. 1997. Signaling through scaffold, anchoring, and adaptor proteins. Science 278:2075-2080.
56. Pelicci, G., F. Grignani, J. McGlade, F. Cavallo, F. Forni, I. Nicoletti, L. Lanfrancone, F. Grignani, T. Pawson, and P. G. Pelicci. 1992. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 70:93-104.
57. Pelicci, G., L. Lanfrancone, A. E. Salcini, A. Romano, S. Mele, M. Grazia-Borrello, O. Segatto, P. P. Di Fiore, and P. G. Pelicci. 1995. Constitutive phosphorylation of Shc proteins in human tumors. Oncogene 11:899-907.
58. Pinkas-Kramarski, R., L. Soussan, H. Waterman, G. Levkowitz, I. Alroy, L. Klapper, S. Lavi, R. Seger, B. J. Ratzkin, M. Sela, and Y. Yarden. 1996. Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. EMBO J. 15:2452-2467.
59. Riese, D. J., E. D. Kim, K. Elenius, S. Buckley, M. Klagsbrun, G. D. Plowman, and D. F. Stern. 1996. The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4. J. Biol. Chem. 271:20047-20052.
60. Robinson, M. J., P. C. Harkins, J. Zhang, R. Baer, J. W. Haycock, M. H. Cobb, and E. J. Goldsmith. 1996. Mutation of position 52 in ERK2 creates a nonproductive binding mode for adenosine 5′-triphosphate. Biochemistry 35:5641-5646.
61. Rozakis-Adcock, M., J. McGlade, G. Mbamalu, G. Pelicci, R. Daly, W. Li, A. Batzer, S. Thomas, J. Brugge, P. G. Pelicci, J. Schlessinger, and T. Pawson. 1992. Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature 360: 689-692.
62. Salcini, A. E., J. McGlade, G. Pelicci, I. Nicoletti, T. Pawson, and P. G. Pelicci. 1994. Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins. Oncogene 9:2827-2836.
63. Sasaoka, T., H. Ishihara, T. Sawa, M. Ishiki, H. Morioka, T. Imamura, I. Usui, Y. Takata, and M. Kobayashi. 1996. Functional importance of amino-terminal domain of Shc for interaction with insulin and epidermal growth factor receptors in a phosphorylation-independent manner. J. Biol. Chem. 271:20082-20087.
64. Sasaoka, T., W. J. Langlois, F. Bai, D. W. Rose, J. W. Leitner, S. J. Decker, A. Saltiel, G. N. Gill, M. Kobayashi, B. Draznin, and J. M. Olefsky. 1996. Involvement of ErbB2 in the signaling pathway leading to cell cycle progression from a truncated epidermal growth factor receptor lacking the C-terminal autophosphorylation sites. J. Biol. Chem. 271:8338-8344.
65. Satoh, T., M. Nakafuku, A. Miyajima, and Y. Kaziro. 1991. Involvement of ras p21 protein in signal-transduction pathways from interleukin 2, interleukin 3, and granulocyte/macrophage colony-stimulating factor, but not from interleukin 4. Proc. Natl. Acad. Sci. USA 88:3314-3318.
66. Saxton, T. M., I. van Oostveen, D. Bowtell, R. Aebersold, and M. R. Gold. 1994. B cell antigen receptor cross-linking induces phosphorylation of the p21ras oncoprotein activators SHC and mSOS1 as well as assembly of complexes containing SHC, GRB-2, mSOS1, and a 145-kDa tyrosine-phosphorylated protein. J. Immunol. 153:623-636.
67. Schlessinger, J., and A. Ullrich. 1992. Growth factor signaling by receptor tyrosine kinases. Neuron 9:383-391.
68. Seger, R., and E. G. Krebs. 1995. The MAPK signaling cascade. FASEB J. 9:726-735.
69. Selva, E., D. L. Raden, and R. J. Davis. 1993. Mitogen-activated protein kinase stimulation by a tyrosine kinase-negative epidermal growth factor receptor. J. Biol. Chem. 268:2250-2254.
70. Shibuya, H., M. Yoneyama, J. Ninomiya-Tsuji, K. Matsumoto, and T. Taniguchi. 1992. IL-2 and EGF receptors stimulate the hematopoietic cell cycle via different signaling pathways: demonstration of a novel role for c-myc. Cell 70:57-67.
71. Shual, K., A. Ziemiecki, A. F. Wilks, A. G. Harpur, H. B. Sadowski, M. Z. Gilman, and J. E. Darnell. 1993. Polypeptide signalling to the nucleus through tyrosine phosphorylation of Jak and Stat proteins. Nature 366:580-583.
72. Soler, C., C. V. Alvarez, L. Beguinot, and G. Carpenter. 1994. Potent SHC tyrosine phosphorylation by epidermal growth factor at low receptor density or in the absence of receptor autophosphorylation sites. Oncogene 9:2207-2215.
73. Terada, K., Y. Kaziro, and T. Satoh. 1995. Ras is not required for the interleukin 3-induced proliferation of a mouse pro-B cell line. BaF3. J. Biol. Chem. 270:27880-27886.
74. Threadgill, D. W., A. A. Dlugosz, L. A. Hansen, T. Tennenbaum, U. Lichti, D. Yee, C. LaMantia, T. Mourton, K. Herrup, R. C. Harris, et al. 1995. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science 269:230-234.
75. Tridandapani, S., T. Kelley, M. Pradhan, D. Cooney, L. B. Justement, and K. M. Coggeshall. 1997. Recruitment and phosphorylation of SH2-containing inositol phosphatase and Shc to the B-cell Fc gamma immunoreceptor tyrosine-based inhibition peptide motif. Mol. Cell. Biol. 17:4305-4311.
76. Vlahos, C. J., W. F. Matter, K. Y. Hui, and R. F. Brown. 1994. A specific inhibitor of phosphatidylinositol-3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269:5241-5248.
77. Walker, F., M. L. Hibbs, H.-H. Zhang, L. J. Gonez, and A. W. Burgess. Biochemical characterization of mutant EGF receptors expressed in the hemopoietic cell line BaF/3. Growth Factors, in press.
78. Welham, M. J., V. Duronio, K. B. Leslie, D. Bowtell, and J. W. Schrader. 1994. Multiple hemopoietins, with the exception of interleukin-4, induce modification of Shc and mSos1, but not their translocation. J. Biol. Chem. 269:21165-21176.
79. Wood, K. W., C. Sarnecki, T. M. Roberts, and J. Blenis. 1992. ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase. Raf-1, and RSK. Cell 68:1041-1050.
80. Wright, J. D., C. W. Reuter, and M. J. Weber. 1995. An incomplete program of cellular tyrosine phosphorylations induced hy kinase-defective epidermal growth factor receptors. J. Biol. Chem. 270:12085-12093.
81. Yamamori, B., S. Kuroda, K. Shimizu, K. Fukui, T. Ohtsuka, and Y. Takai. 1995. Purification of a Ras-dependent mitogen-activated protein kinase kinase kinase from bovine brain cytosol and its identification as a complex of B-Raf and 14-3-3 proteins. J. Biol. Chem. 270:11723-11726.
82. Zhang, K., J. Sun, N. Liu, D. Wen, D. Chang, A. Thomason, and S. K. Yoshinaga. 1996. Transformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2. J. Biol. Chem. 271:3884-3890.